February 2026 in “Toxicology Letters” MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.
December 2025 in “Phytomedicine Plus” Combining herbal medicines with modern delivery systems may improve alopecia treatment.
October 2025 in “Asian Journal of Pharmaceutical Research and Development” Combining natural extracts with modern science creates effective and safe hair-care products.
August 2025 in “Journal of Ayurveda and Integrated Medical Sciences” Combining Ayurvedic and modern treatments can effectively manage hair loss.
Psoriasis patients should do moderate exercise like walking or yoga for 30 minutes, 4-5 times a week.
March 2024 in “Frontiers in genetics” Xiangdong black goats have moderate genetic diversity, minimal inbreeding, and important genes for reproduction, immunity, and other traits.
May 2023 in “Elsevier eBooks” The book teaches modern, non-invasive hair restoration techniques for common hair loss.
January 2020 in “Hair therapy & transplantation” FUE is a modern hair transplant method that avoids large scars and is good for short hair.
April 2017 in “Journal of Investigative Dermatology” Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.
July 2013 in “The Journal of Clinical Endocrinology & Metabolism” People with moderate or severe hair loss have higher death rates from diabetes and heart disease.
September 2012 in “DOAJ (DOAJ: Directory of Open Access Journals)” D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.
PRP treatment mildly to moderately improves hair loss in most men with AGA.
June 2013 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” People with moderate or severe hair loss are at a higher risk of dying from diabetes and heart disease.
3 citations
,
January 2023 in “Indian Dermatology Online Journal” COVID-19 vaccines can cause mild to moderate skin reactions, mostly after the first dose.
77 citations
,
December 2004 in “Choice Reviews Online” The document summarized how various modern drugs are made.
68 citations
,
April 2002 in “Journal of Alternative and Complementary Medicine” Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.
41 citations
,
February 2021 in “Cureus” Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.
29 citations
,
May 1975 in “Clinical Endocrinology” Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.
25 citations
,
December 2022 in “Indonesian Journal of Science and Technology” Peanut stem extract has strong antioxidants and moderate cancer-fighting potential.
20 citations
,
April 2020 in “Journal of advanced Biomedical and Pharmaceutical Sciences” Niosomal methylene blue gel effectively improves moderate to severe acne.
3 citations
,
September 2025 in “Frontiers in Immunology” JAK inhibitors are effective for treating moderate-to-severe alopecia areata.
3 citations
,
September 2019 in “Journal of The American Academy of Dermatology” Low-dose oral minoxidil effectively treats mild-moderate male hair loss, alone or combined with other therapies.
2 citations
,
November 2009 in “DSpace (Federal University of Santa Catarina)” Brunfelsia uniflora has good antioxidant properties and moderate antibacterial activity.
1 citations
,
August 2012 in “Journal of acupuncture and meridian studies” Traditional Korean medicine combined with modern technology may improve hair removal treatments.
May 2026 in “Nursing Reports” Slovak breast cancer survivors have moderate quality of life, with emotional and cognitive strengths but social and physical challenges, needing targeted support.
January 2026 in “Annals of Dermatology” Alitretinoin may help treat mild to moderate alopecia areata.
September 2025 in “Journal of Intellectual Disability Research” Measuring hair glucocorticoids for stress is moderately feasible, especially in females and those with moderate intellectual disabilities.
May 2025 in “Birth Defects Research” YWS1903 is safe for pregnant rats at moderate doses but causes fetal issues at high doses.
January 2025 in “International Journal of Scientific Research” 12.5% of women with PCOS experience moderate hair loss, highlighting the need for early detection and management.
August 2024 in “Clinical and Medical Engineering Live” Alopecia treatment should use a modern, combined approach to effectively address hair loss.